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Abstract 
Background: Sepsis, systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome 
(MODS) remain the most frequent causes of complications and death in severely injured patients. A main reason for 
the development of these syndromes is a post‑traumatic dysregulation of the immune system. Several studies in 
intensive care unit (ICU) patients could detect a pivotal role of HLA‑DR expression on monocytes. So far, its impor‑
tance for development of SIRS, sepsis or MODS in the severely injured patient is not clear.
Methods: Therefore, we have analysed HLA‑DR expression on monocytes from severely injured patients (ISS > 16) 
during the post‑traumatic course, which was on the day of trauma, as well as on days 3, 7 and 14 post trauma. Clinical 
data were analysed and the HLA‑DR expression levels of patients who developed post‑traumatic sepsis, SIRS or MODS 
were compared to those with a more favourable outcome. Young and healthy volunteers as well as patients undergo‑
ing prosthetic hip replacement after trauma were enrolled as control groups. HLA‑DR molecules on monocytes were 
marked with PE‑conjugated antibodies and the mean fluorescence intensity (MFI) was analysed via flow cytometry.
Results: 24 severely injured patients (mean age 34 ± 2.7 years) mainly after high energy motor vehicle accidents as 
well as 8 controls (total hip replacement) and 9 healthy volunteers (mean age 26.2 ± 1.2 years) were enrolled. A total 
of eight patients suffered from sepsis (33.3 %) (six males, two females) and 17 patients suffered from SIRS (70.9 %) (10 
males, 7 females). MODS was present in five patients (20.8 %), three male and two female patients. In four of these 
five patients the MODS developed subsequent to sepsis. HLA‑DR expression significantly decreased after trauma and 
slowly returned to normal after 14 days, irrespective of the complications developed.
Conclusion: In conclusion, post‑traumatic HLA‑DR expression on monocytes is significantly reduced after multiple 
trauma and it is back to normal on day 14. No significant changes in HLA‑DR expression on monocytes from severely 
injured patients suffering from SIRS, MODS or sepsis compared to those who did not have complications could be 
detected. Nevertheless, HLA‑DR expression on monocytes may be used to identify the immunological pro‑ or anti‑
inflammatory phase the patient is going through.
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Background
Sepsis, Systemic Inflammatory Response Syndrome 
(SIRS) and Multiple Organ Dysfunction Syndrome 
(MODS) remain the most frequent causes of complica-
tions and death in severely injured patients. Authors 
could detect a malfunction of the immune system 
after major trauma as one reason for that [1]. The effi-
cient function of the immune system is essential for an 
organism to fight pathogens. The innate immune sys-
tem represents the first line of host defence. It performs 
phagocytosis as well as releases cytokines, thus activating 
the adaptive immune system. Surgical stress and trauma 
also lead to an activation of the innate immune system 
[2, 3]. In this case, so-called danger-associated molecu-
lar patterns have been identified as danger signals that 
mediate the early post-traumatic inflammatory response 
[2, 3]. Both pathogen- and danger-associated molecular 
patterns are recognized by immunologically competent 
cells [4]. HLA-DR molecules play a central role in the 
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specific immune response, as they are required for anti-
gen presentation and activation of helper T lymphocytes. 
These molecules are expressed on the surface of profes-
sional antigen-presenting cells such as macrophages or 
dendritic cells. Several studies have shown that HLA-DR 
expression on monocytes decreases after major injury, 
surgery and organ transplantation [5, 6]. Reduced HLA-
DR expression on monocytes was considered to correlate 
with infectious complications and the development of 
sepsis.
One critical aspect following trauma is the ability of 
the organism to present MHC II antigens (HLA-DR) on 
monocytes, because the T helper cells will only react to 
foreign antigens that are presented on the macrophage 
surface using HLA-DR. Studies could show that in 
patients with an uneventful recovery from severe trauma 
or surgery, the level of monocyte HLA-DR expression 
fell within hours of trauma or surgery, but returned to 
normal within 1  week [6, 7]. In contrast, 3  weeks were 
required for HLA-DR expression to return to base level 
in those who developed infection, but finally recovered. 
Interestingly, in those who developed infection and sepsis 
and died as a result, HLA-DR expression decreased and 
never regained base levels.
Numerous markers of immune failure have been 
described in patients. Among these, the decreased 
expression on circulating monocytes of HLA-DR meas-
ured by flow cytometry has repeatedly been described as 
a robust marker of immune dysfunctions in septic shock 
patients [5]. So far, not many data exist about the asso-
ciation between HLA-DR expression on monocytes of 
severely injured patients and the development of a post 
traumatic SIRS, or MODS. Several studies are published 
regarding the HLA-DR expression and development of 
sepsis in patients after abdominal surgery or during long 
ICU stay; only one publication exists concerning the 
HLA-DR expression in polytraumatized patients with 
sepsis [8].
Up to now, the post traumatic kinetics of HLA-DR 
expression levels on monocytes after polytrauma has 
sparsely been shown. Moreover, it is not completely clear 
whether the HLA-DR expression on monocytes of pol-
ytraumatized patients is different on those who develop 
sepsis, SIRS or MODS during the post-traumatic course. 
As the early detection of the patients at risk for develop-
ment one of these highly feared complications is most 
important for early treatment, this could be of great 
importance for the treatment of those patients during 
ICU stay. Therefore, the aim of this study was to analyse 
the HLA-DR expression on monocytes from polytrau-
matized patients during a 14-day post-traumatic course. 
Furthermore, it was the aim to investigate whether these 
kinetic changes were associated with the development of 
sepsis, SIRS or MODS.
Patients and methods
Patients
Consecutively, 24 blunt trauma patients were included in 
the study. Inclusion criteria were primary admittance to 
our department and Injury Severity Score (ISS) >16. Cri-
teria for the exclusion of patients were patients younger 
than 18 or older than 65  years, admission  >8  h after 
injury, penetrating injuries, pregnancy, premedication 
with immunosuppressive agents, and underlying car-
diac, pulmonary, hematologic, or immunologic diseases. 
A control group of surgery patients undergoing total hip 
replacement was analysed as well. 2.7  ml EDTA blood 
samples were taken in both groups on admission, on days 
3, 7 and 14. Blood sampling was conducted in accordance 
with the Declaration of Helsinki in its latest amendment. 
The local ethical institutional review board approved the 
study protocol (Nr. 2167). Informed and written con-
sent was obtained from all trauma patients, all healthy 
volunteers and all control group patients or from their 
relatives.
Moreover, blood was taken from healthy individuals 
to determine a physiologic value of HLA-DR expression 
without trauma.
Sepsis, SIRS, MODS
Existence of sepsis, SIRS or MODS was checked every 
day within the first 2 weeks after trauma. For the diagno-
sis “sepsis”, SIRS should be present and candida or bacte-
ria had to be found in the systemic circulation.
For the existence of a SIRS, two of the following criteria 
had to be fulfilled [9, 10]:
1. Body temperature >38 or <36 °C
2. Heart rate >90 per minute
3. Breathing frequency >20 per minute or 
PaCO2 >4.3 kPa
4. White blood count >12,000 per μl or <4000 per μl or 
more than 10 % immature cells
For detection of MODS, the GORIS score was chosen. 
In this scoring system different points are given for the 
function of the seven organ systems (lung, heart, kid-
ney, liver, blood, gastrointestinal tract, central nervous 
system). A normal organ function is scored with zero 
points while a total organ dysfunction gets 2 points [11]. 
Patients with a GORIS score of seven or more points on 
three consecutive days were considered to suffer from 
MODS.
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HLA‑DR on monocytes
50  µl of the blood sample was mixed with 20  µl of anti-
body cocktail, which consisted of anti-HLA-DR PE and 
anti-CD14-CD64-PerCP-Cy5.5. (Becton–Dickinson, San 
Jose, CA, USA) in a FACS tube (Becton–Dickinson, Frank-
lin Lakes, NJ, USA). This mixture was incubated at room 
temperature for 30 min. Then 45 µl of FACS Lysing Solu-
tion (Becton–Dickinson, San Jose, CA, USA) together with 
405 µl distilled water was added and incubated for at least 
10 min. After that time, the erythrocytes were lysed and a 
suspension of leukocytes was present. This suspension was 
used for flow cytometric analysis. After gating of the mono-
cytes in the PerCP-Cy5.5 canal, a frequency bar chart of 
the PE canal’s intensity was generated. On the basis of the 
frequency bar chart, the mean intensity of each sample was 
analysed. Afterwards, on the basis of the mean intensity of 
each sample, the mean number of HLA-DR molecules on 
each monocyte could be determined by using a calibration 
series, which revealed the number of PE marked molecules 
per analysed mean intensity on the monocytes.
Quantification of the monocytic HLA-DR was per-
formed using the program Cell Quest Pro.
Statistical analysis
Results are presented as mean ± SEM. A one-way anal-
ysis of variance (ANOVA) and a multivariant Wilks’ 
Lambda were performed to determine significant differ-
ences between experimental means. A p value of  <0.05 
was considered statistically significant.
Results
Patients
24 polytraumatized patients were enrolled, of which 
14 were males and 10 females. The mean age was 
34 ± 2.7 years, ranging from 18 to 62 years. All patients 
survived the observation period of 14 days. The ISS was 
28.4 ± 7.5.
A total of eight patients suffered from sepsis (33.3  %) 
(six males, two females), mean age was 37.3 ± 5.6 years, 
mean ISS was 27.8  ±  10.4 points and 18 patients suf-
fered from SIRS (70.9 %) (11 males, 7 females), mean age 
was 32.4 ±  2.9  years and the mean ISS was 28.5 ±  8.2 
points. MODS was present in five patients (20.8  %), 
three male and two female patients, the mean age was 
33.6 ± 4.6 years and the mean ISS was 24.4 ± 5.9 points. 
In four of these five patients the MODS developed sub-
sequent to sepsis. More detailed patient information is 
summarized in Table 1.
Control patients
The mean age of the 8 surgery control patients was 
69 ± 4.5 years, ranging from 42 to 84 years. Five patients 
were males and 3 were females.
Healthy volunteers
Besides, 9 healthy volunteers between 23 and 35  years 
(26.2 ± 1.2 years) were enrolled. Of these, 6 were males 
and 3 were females. A blood sample was taken once and 
the MFI was taken as blank value for all measuring points 
of the polytrauma patients and the controls, respectively.
Mean fluorescence intensity (MFI) in polytrauma, control 
and healthy volunteers
On day 1 after trauma, the MFI of all trauma patients was 
362.8 ±  14.6. Compared to day 1, the MFI significantly 
decreased on day 3 (320.3 ± 10.7, p < 0.01) and increased 
again but not significantly on day 7 (340 ± 16.3). In the 
following course, MFI significantly increased further on 
day 14 (488 ± 23.8; p < 0.0001). On day 1, the MFI value 
of the surgery control patients was 319.7  ±  17.9. The 
control group showed a steady and significant increase 
of the MFI during the observation period, with values 
of 388 ± 34.7 on day 3 (p = 0.03), 460.4 ± 60 on day 7 
and 572.8  ±  57.7 on day 14 (p  <  0.05). The mean MFI 
of the healthy group was 592.3 ± 54.3. The surgery and 
polytrauma patients showed a significant decrease of the 
HLA-DR expression on day 1 compared to the healthy 
control group. While the HLA –DR expression in the 
surgery control group could already on day 7 reach a level 
close to baseline, the trauma patients needed 14  days 
(Fig. 1).
MFI in MODS
Five patients developed a MODS during the observation 
period, whereas 19 patients had normal organ functions.
Patients with MODS showed the same trend as the 
overall polytrauma collective. MFI in patients with 
MODS was trend wise more decreased on day 3 and 7 
compared to patients without MODS. However, differ-
ences were not significant (Fig. 2).
MFI in SIRS
From the twenty-four polytraumatized patients, seven-
teen were suffering from SIRS. The MFI was reduced on 
day 3 and increased significantly on day 7 and 14, respec-
tively. Patients without SIRS showed the same post-trau-
matic course of MFI with similar values (Fig. 3).
MFI in sepsis
Eight out of the twenty-four polytraumatized patients 
developed sepsis during the post-traumatic course. In 
the systemic circulation of all septic patients, bacteria 
(haemolytic staphylococcus, staphylococcus epidermidis, 
enterobacter aerogenes) or candida could be detected. 
Patients suffering from sepsis showed decreased MFI 
values on day 3 and 7 post-trauma with a significant 
increase on day 14 compared to patients without sepsis. 
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In contrast to the patients with sepsis, the MFI reduc-
tion on day 3 and 7 was only marginal in patients without 
sepsis while the significant increase on day 14 could be 
detected as well (Fig. 4).
Discussion
In the present study, the post -traumatic kinetic of 
HLA-DR expression on monocytes after polytrauma 
compared to surgery and healthy volunteers has been 
analysed. Moreover, the use of HLA-DR expression on 
monocytes as a prognostic marker for development of 
MODS, SIRS and sepsis in polytraumatized patients has 
extensively been researched and analysed. A significant 
decrease in HLA-DR expression on monocytes during 
the first 14 days after severe trauma could be detected. 
This result comes along with the findings of several other 
authors analysing HLA-DR levels after surgery or organ 
transplantation [12–15]. Persisting low HLA-DR values 
Table 1 Demographic data of the severely injured patient collective
Gender Age (years) Diagnosis MODS SIRS Sepsis
Male 37 Craniocerebral injury II°, Rip fractures, lung contusion, upper spine fractures, thigh fracture No Yes No
Male 19 Craniocerebral injury I°, fracture of the mandible, spleen rupture, tibialhead fracture, lumbal vertebrae 
fracture
No Yes No
Male 18 Craniocerebral injury I°, lung contusion, hip fracture No No No
Female 28 Craniocerebral injury II°, rip fractures, lung contusions bilateral, spleen rupture, kidney contusion, verte‑
brae fractures
No Yes No
Male 49 Craniocerebral injury II° with brain contusion, rip fractures, haemato and pneumothorax, lung contusion, 
spleen rupture
Yes Yes Yes
Female 49 Craniocerebral injury III°, intracerebral bleeding, orbita and maxilla fractures, lung contusions bilateral, 
monteggia luxation fracture with open upper arm fracture
No No No
Female 22 Craniocerebral injury II°, rip fractures, lung contusions bilateral, lower leg fractures bilateral, forearm 
fractures bilateral
No Yes No
Female 41 Craniocerebral injury II°, serial rip fractures, lung contusions bilateral, bilateral tibia fractures, bilateral 
forearm fractures
No Yes No
Male 31 Craniocerebral injury with skull fracture, open patella fracture rip fractures, haemato and pneumothorax, 
lung contusions bilateral, acetabulum fracture,
No No No
Female 30 Craniocerebral injury II°, lung contusions bilateral, thoracic spine fracture, acetabulum fracture Yes Yes No
Female 53 Craniocerebral injury I°, lung contusion, rip fractures, pneumothorax, liver contusion, open tibial head 
fracture, open patella fracture, anterior crucial ligament and posterior crucial ligament rupture, pelvis 
fracture
No Yes Yes
Male 27 Fracture of the mandible, nose fracture, kidney rupture, pelvis fracture, acetabulum fracture, forearm 
fracture right, open lower leg fracture right, fibula fracture left
No Yes No
Male 62 Craniocerebral injury I°, cheekbone fracture, rip fractures, haematopneumothorax, spleen and liver rup‑
ture, acetabulum fracture, thoracic spine fracture, pelvic fracture, retroperitoneal haematoma
No Yes Yes
Male 18 Craniofacial fractures, lung contusion, fibula fracture, posterior crucial ligament rupture, ankle fracture, 
calcaneus fracture radius fracture, ulna fracture
No Yes Yes
Male 24 Rip fracture right, thoracic vertebral fractures, open upper thigh fracture left, open lower leg fracture 
with rupture of the arteria tibialis posterior left, calcaneus fracture left, open upper arm fracture right, 
open ankle fracture right
No Yes No
Male 31 Pneumothorax right, spleen rupture left, kidney rupture left, pelvis fracture bilateral with rupture of the 
urethra, lumbal vertebral fracture, foot fracture right
No No No
Male 59 Le Fort fracture III° left, Le Fort fracture II° right, lumbal vertebral fractures, distal femur fracture right, 
open pilon‑tibial fracture
No No No
Male 27 Craniocerebral injury I°, rip fractures 5‑10 left, lung contusion left, spleen rupture, patella fracture No Yes Yes
Male 36 Craniocerebral injury III° with open skull fracture, acetabular fracture, sacrum fracture, tibia fracture Yes Yes Yes
Female 53 Craniocerebral injury II°, fracture of the sternum, serial rip fractures, haematopneumothorax bilateral, 
ileum fracture, thoracic spine fracture, fracture of the tibial head, contusio cordis
No No No
Male 32 Vertebral fractures in the thoracic and lumbal spine, olecranon fracture, serial rip fractures, lung contu‑
sions bilateral, spleen contusion, haematoma of the psoas
Yes Yes Yes
Female 30 Pneumothorax, spleen laceration, bilateral thigh fractures, patellar tendon rupture, pelvis fracture No Yes No
Female 18 Craniocerebral injury II°, serial rip fractures, lung contusions bilateral, thigh fracture, liver contusion No No No
Female 21 Haematopneumothorax, lung contusions bilateral, sacrum fracture, lumbal spine fracture, blunt abdomi‑
nal trauma
Yes Yes Yes
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Fig. 1 HLA‑DR expression on monocytes from polytraumatized patients (n = 24), patients after total hip replacement surgery (n = 8) and healthy 
volunteers (n = 9). *p < 0.001 polytrauma patients and surgery group vs. healthy volunteers post trauma and days 3 and 7. °p < 0.05 surgery group 
post trauma vs. days 3, 7 and 14. Polytrauma patients: #p < 0.01 significant decrease day 3 vs. post trauma. #p < 0.0001 significant increase day 14 vs. 
post trauma (one way ANOVA, Wilks´ Lambda)
Fig. 2 Patients with MODS (n = 5) showed decreased HLA‑DR expression levels on monocytes compared to those who did not develop MODS 
(n = 19). Approximately on day 10 post trauma HLA‑DR expression levels are alike
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Fig. 3 HLA‑DR expression on monocytes from polytraumatized patients suffering from SIRS (n = 17) and those who did not develop a SIRS (n = 7). 
As nearly 70 % of the analysed collective developed SIRS, the curves are almost identical
Fig. 4 Patients with sepsis after polytrauma (n = 8) showed a sudden decrease of monocytic HLA‑DR expression levels immediately after trauma 
while patients without sepsis (n = 16) could hold a steady expression level. After 7 days both groups are back on one similar level
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were found in patients who subsequently developed sec-
ondary infections, whereas HLA-DR levels increased 
generally within 1  week in individuals who recovered 
uneventfully [6 , 8, 16, 17]. Previously, HLA-DR expres-
sion was usually assessed as a predictor of septic com-
plications after trauma, surgery or pancreatitis [6, 8, 16, 
17], but no statements concerning MODS or SIRS were 
made so far. Only one study deals with sepsis develop-
ment in polytraumatized patients and HLA-DR expres-
sion on monocytes but in this study neither MODS nor 
SIRS development was analysed. Moreover, neither the 
healthy HLA-DR expression in volunteers nor the HLA-
DR expression after surgery had been analysed as con-
trol groups. In contrast, Ditschkowski et  al. separated 
the polytrauma collective in three groups depending on 
the severity of injury [8]. In contrast to Ditschkowski 
et  al. no significant differences between the HLA-DR 
expression of polytrauma patients with sepsis and with-
out sepsis could be found in this study. One reason for 
this might be the patient number. While Ditschkowski 
et al. enrolled 77 patients of whom 20 developed a sep-
sis, we could include 24 patients of whom eight devel-
oped a sepsis. Although we have enrolled less patients, 
the sepsis rate of both collectives was more or less 30% . 
The HLA-DR expression curves in our study looked 
similar to the ones from Ditschkowski et al. and they fol-
lowed the same trend [8].
Other authors could also show a correlation between 
a decreased HLA-DR expression on monocytes and the 
development of a sepsis during the post-operative course 
[18–20]. These data are not comparable with the pre-
sented results, as they have analysed different patient 
groups like burn patients or patients suffering from 
abdominal or vascular surgery. Nevertheless, a trend 
towards lower HLA-DR expression could be observed in 
our sepsis patients.
We believe that polytrauma patients cannot be 
compared with patients suffering from sepsis due to 
nosocomial infections, burns or abdominal surgery com-
plications because the immunological processes after a 
polytrauma are different. Due to polytrauma, the patient 
has to face the first immunological hit (e.g. hypoxia, 
hypotension, organ and soft tissue injuries, fractures), 
followed by a second hit (e.g. ischaemia/reperfusion inju-
ries, operative interventions, infections). This induces 
a host defence response, which is characterized by local 
and systemic release of pro-inflammatory cytokines, 
complement factors and acute phase proteins, as well 
as hormonal mediators. In parallel, anti-inflammatory 
mediators are produced (compensatory anti-inflamma-
tory response syndrome, CARS). An imbalance here 
mayo be responsible for organ dysfunction and increased 
susceptibility to infections.
Therefore, the HLA-DR expression may be dependent 
on the pro- or anti-inflammatory phase the individual is 
passing through at the moment of blood collection. SIRS 
is defined as a hyper-inflammatory phase and, therefore, 
associated with normal or raised HLA-DR expression 
[21].
Later during the anti-inflammatory phase, CARS, the 
production of anti-inflammatory mediators is increased 
and monocytes downregulate the HLA-DR expression 
[21]. Especially, IL-10 causes an internalization of HLA-
DR thus decreasing the HLA-DR expression on mono-
cytes. This can be prevented by anti-IL-10 treatment. 
Thus, in individual patients, profound CARS is associated 
with low numbers of HLA-DR expressing monocytes. 
However, in other patients the blood sample might have 
been taken while the individual was in the SIRS phase, in 
which case monocyte HLA-DR may be normal or raised 
whatever the prognosis of the patient. Measurements of 
monocyte HLA-DR expression may be worth pursuing as 
one possible indicator as to whether the patient is in an 
inflammatory or anti-inflammatory phase.
Some studies exist analysing the different impact of 
ageing on monocytic HLA-DR expression. Seidler et al., 
for example, could show a decrease of monocyte HLA-
DR expression in aged healthy volunteers (>50  years). 
The difference was significant compared to the very 
young control group (<30 years) but it was not significant 
compared tot he middle aged (>30 years) [22]. Others did 
not find any correlation with HLA-DR expression and 
age [23]. Therefore, we do not think that the age differ-
ence between our study group (ca. 30 years) and the sur-
gery group (ca. 69 years) is crucial for our results.
20 % of our severely injured patients developed MODS 
during the post traumatic course, which is comparable 
with results from other studies, analysing patients with 
blunt abdominal trauma, with MODS rates between 7.9 
and 26.1 % [24].
Decreased expression of HLA-DR on monocytes is 
a hallmark of altered immune status in patients with 
SIRS. West et  al. could show that HLA-DR expression 
on monocytes correlates with injury severity [25]. They 
could also show decreased monocytic HLA-DR lev-
els 48  h after trauma as others have shown before [25, 
26]. This comes along with our results. Nevertheless, 
we could not detect significant differences of HLA-DR 
expression on monocytes of patients suffering from SIRS 
and those who did not after multiple trauma.
Kim et  al. could detect that HLA-DR expression is 
differently modulation on CD14HIGH (classical) and 
CD14LOW (inflammatory) monocytes after systemic 
inflammation.This shows that also the HLA-DR expres-
sion on monocyte subpopulations is involved in the 
development of a SIRS [27].
Page 8 of 9Vester et al. Eur J Med Res  (2015) 20:84 
There are several limitations to this study. First, the 
group size of 24 polytraumatized patients is very small. 
This is due to the fact that the analysed patient popula-
tion, traumatized patients with an ISS  >16 points, is a 
rare entity. Nevertheless, more studies with a bigger 
collective are needed. Moreover, HLA-DR expression 
on monocytes was analysed only at some time points 
(directly after trauma, 3, 7 and 14  days post trauma). 
Therefore, significant changes in between might be 
missed. However, the time curve after severe trauma and 
the important time points have been extensively studied 
during the past decades and most immune responses are 
detected during the first 14 days with a peak directly after 
trauma up to 3 days postop [28].
In conclusion, post-traumatic HLA-DR expression 
on monocytes is significantly reduced after multiple 
trauma. HLA-DR levels are at 14  days normal. No sig-
nificant changes in HLA-DR expression on monocytes 
from severely injured patients suffering from SIRS, 
MODS or sepsis compared to on those who did not have 
complications could be detected. Nevertheless, HLA-
DR expression on monocytes may be used to identify 
the immunological pro- or anti-inflammatory phase 
the patient is going through in combination with other 
immunological markers. More studies with a larger pol-
ytrauma collective are needed to confirm and widen 
our knowledge about post-traumatic immune system 
dysfunctions.
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